Lantheus Holdings, Inc. (NASDAQ:LNTH) Director David F. Burgstahler sold 91,166 shares of Lantheus Holdings stock in a transaction dated Monday, August 28th. The shares were sold at an average price of $17.01, for a total transaction of $1,550,733.66. Following the sale, the director now directly owns 13,248 shares in the company, valued at approximately $225,348.48. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Shares of Lantheus Holdings, Inc. (LNTH) opened at 17.00 on Tuesday. The company’s 50-day moving average is $17.79 and its 200 day moving average is $14.77. Lantheus Holdings, Inc. has a 1-year low of $7.18 and a 1-year high of $20.45. The company has a market cap of $634.95 million, a price-to-earnings ratio of 23.22 and a beta of 0.91.

Lantheus Holdings (NASDAQ:LNTH) last issued its quarterly earnings results on Tuesday, August 1st. The medical equipment provider reported $0.42 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.24 by $0.18. The company had revenue of $88.83 million for the quarter, compared to analyst estimates of $80.56 million. Lantheus Holdings had a net margin of 8.44% and a negative return on equity of 37.47%. The business’s revenue for the quarter was up 13.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.24 earnings per share. Equities analysts anticipate that Lantheus Holdings, Inc. will post $1.12 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Lantheus Holdings, Inc. (LNTH) Director David F. Burgstahler Sells 91,166 Shares” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of international trademark & copyright law. The correct version of this news story can be read at https://www.thecerbatgem.com/2017/08/29/lantheus-holdings-inc-lnth-director-david-f-burgstahler-sells-91166-shares.html.

Institutional investors have recently made changes to their positions in the company. State of Alaska Department of Revenue bought a new position in shares of Lantheus Holdings during the second quarter worth approximately $102,000. Municipal Employees Retirement System of Michigan bought a new position in shares of Lantheus Holdings during the second quarter worth approximately $107,000. LS Investment Advisors LLC bought a new position in shares of Lantheus Holdings during the second quarter worth approximately $112,000. Quantbot Technologies LP bought a new position in shares of Lantheus Holdings during the second quarter worth approximately $117,000. Finally, Teachers Retirement System of The State of Kentucky bought a new position in shares of Lantheus Holdings during the second quarter worth approximately $141,000. 84.35% of the stock is owned by institutional investors and hedge funds.

LNTH has been the topic of a number of research reports. Zacks Investment Research raised shares of Lantheus Holdings from a “hold” rating to a “strong-buy” rating and set a $17.00 target price on the stock in a research note on Thursday, May 4th. Credit Suisse Group lifted their target price on shares of Lantheus Holdings from $14.00 to $19.00 and gave the company a “neutral” rating in a research note on Wednesday, August 2nd. Jefferies Group LLC reaffirmed a “buy” rating and set a $22.00 target price (up previously from $18.00) on shares of Lantheus Holdings in a research note on Wednesday, August 2nd. Cantor Fitzgerald initiated coverage on shares of Lantheus Holdings in a research note on Monday, July 17th. They set an “overweight” rating and a $22.00 target price on the stock. Finally, BidaskClub lowered shares of Lantheus Holdings from a “strong-buy” rating to a “buy” rating in a research note on Thursday, August 17th. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $18.60.

Lantheus Holdings Company Profile

Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.

Insider Buying and Selling by Quarter for Lantheus Holdings (NASDAQ:LNTH)

Receive News & Stock Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related stocks with our FREE daily email newsletter.